LECT2 and metabolic dysfunction-associated steatotic liver disease: Recently, accumulating evidence has indicated that LECT2 played crucial roles in various diseases, including diabetes (Lan et al., 2014), lung cancer (Hung et al., 2018), liver cancer (Ong et al., 2011; Chen et al., 2014; L’Hermitte et al., 2019), NAFLD (Yoo et al., 2017), and so on.